Intelgenx Technologs (IGXT) 0.5468 $IGXT IntelGenx to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intelgenx Technologs (IGXT) 0.5468 $IGXT

IntelGenx to Initiate Phase 1 Trial of Montelukast
Marketwire Canada - Wed Jul 13, 7:31AM CDT
SAINT-LAURENT, CANADA--(Marketwired - Jul 13, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the recent initiation of a phase 1 clinical trial of montelukast, a unique drug repurposing opportunity for the treatment of degenerative diseases of the brain, such as: mild cognitive impairment and Alzheimers disease, the most prominent form of dementia. The objectives of the trial are to demonstrate: 1. IntelGenx oral film product will provide therapeutically effective blood levels of montelukast, and; 2. montelukast when delivered using IntelGenx oral film crosses the blood brain barrier.
IGX.VN: 0.710 (+0.020)

IntelGenx Announces Notice of Appeal for Buprenorphine/Naloxone Sublingual Film Product for the Treatment of Opiate Addiction
Marketwire Canada - Mon Jul 11, 3:00PM CDT
SAINT-LAURENT, QUEBEC--(Marketwired - Jul 11, 2016) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the receipt of the recent notice of appeal for the buprenorphine/naloxone sublingual film product for the treatment of opiate addiction by Par Pharmaceutical, Inc. and IntelGenx Corp. to the United States Court of Appeals for the Federal Circuit from the final judgment issued by the U.S. District Court for the District of Delaware on June 28, 2016.
IGX.VN: 0.710 (+0.020)

IntelGenx Reports Amendment of Stock Option Plan
Marketwire Canada - Thu May 12, 3:01PM CDT
SAINT LAURENT, QUEBEC--(Marketwired - May 12, 2016) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx" reported today, that the Company's Board of Directors approved to amend the 2006 Stock Option Plan and to redesignate it as the "2016 Stock Option Plan". The number of shares available for issuance under the new Plan increased by 1,331,233 from 5,030,292 to 6,361,525, or 10% of the Company's issued and outstanding shares as of May 10, 2016. The 2016 Stock Option Plan is available on EDGAR and SEDAR for a complete review of the amendments.
IGX.VN: 0.710 (+0.020)

IntelGenx Reports First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
SAINT LAURENT, QUEBEC--(Marketwired - May 10, 2016) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx" today reported its first quarter 2016 financial results for the three-month period ended March 31, 2016. All amounts are in U.S. Dollars unless otherwise stated. The Company will host a conference call to provide a corporate update on Thursday, May 12th at 9:00 a.m. ET. Details of the conference call and webcast are listed below in this release.
IGX.VN: 0.710 (+0.020)

IntelGenx to Report First Quarter 2016 Financial Results on May 10, 2016
Marketwired - Thu May 05, 5:01PM CDT
SAINT LAURENT, QUEBEC--(Marketwired - May 5, 2016) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) ("IntelGenx", today announced that it will release its first quarter 2016 financial results on May 10, 2016 at 4:00 p.m. ET followed by the annual general meeting of shareholders. A special presentation will then be made by Dr. Ludwig Aigner on "Rejuvenation of the aged brain - an example of drug delivery in drug repurposing." Shareholders are then invited to the company's grand opening of its brand new state-of-the-art manufacturing facilities where tours will be offered.
IGX.VN: 0.710 (+0.020)

IntelGenx and RedHill Biopharma Announce RIZAPORT(TM) Commercialization Term Sheet With Grupo Juste for Spain and Additional Potential Territories
Marketwired - Tue Mar 29, 6:01AM CDT
IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) and RedHill Biopharma Ltd. (NASDAQ: RDHL)(TASE: RDHL) today announced the binding term sheet agreement with Grupo Juste S.A.Q.F for the commercialization of RIZAPORT(TM), a unique oral thin film for the treatment of acute migraines in the country of Spain. The definitive agreement plans to be signed within 60 days of the execution of the binding term sheet. Financial terms of the agreement were not disclosed.
RDHL: 12.46 (+0.16), IGX.VN: 0.710 (+0.020)

RedHill Biopharma and IntelGenx Announce RIZAPORT(TM) Commercialization Term Sheet with Grupo JUSTE for Spain and Additional Potential Territories
GlobeNewswire - Tue Mar 29, 6:00AM CDT
-- RedHill and its co-development partner, IntelGenx Corp., have entered into a binding term sheet with Grupo JUSTE granting an exclusive license to commercialize their acute migraine drug RIZAPORTin Spain, and a right of first refusal for additional territories
RDHL: 12.46 (+0.16), IGX.VN: 0.710 (+0.020)

IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical Company for Up to Three Products
Marketwired - Thu Mar 24, 11:05AM CDT
IntelGenx Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced the signing of a term sheet with a global pharmaceutical company for the development and commercialization of up to three products utilizing IntelGenx' proprietary VersaFilm(TM) technology. Pursuant to the term sheet, IntelGenx granted an exclusive negotiation period during which time the parties will conduct diligence and work towards entry into a definitive agreement. IntelGenx receives $100,000 at the time of signing the term sheet, in consideration for granting an exclusive negotiation right. If entered into, IntelGenx expects the definitive agreement to be finalized by the second quarter of 2016.
IGX.VN: 0.710 (+0.020)

IntelGenx to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Financial Results on Wednesday, March 23
Marketwired - Wed Mar 09, 7:31AM CST
IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) ("IntelGenx", today announced that it will release its fourth quarter and full-year 2015 financial results on March 22, 2016 at the close of the financial markets.
IGX.VN: 0.710 (+0.020)

IntelGenx Files Loxapine Oral Film Patent for Schizophrenia
Marketwired - Wed Feb 10, 7:31AM CST
IntelGenx Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it has submitted a patent application with the US patent office for an oral film dosage form containing Loxapine for the treatment of anxiety and aggression in patients suffering from schizophrenia or bipolar 1 disorder.
IGX.VN: 0.710 (+0.020)

IntelGenx Announces Creation of a Scientific Advisory Board
Marketwired - Thu Feb 04, 7:31AM CST
IntelGenx Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it has further strengthened its organization with the creation of a Scientific Advisory Board with the engagement of Dr. Ludwig Aigner and Dr. Barry Greenberg. Dr. Horst G. Zerbe will act as the Chairman and Ms. Nadine Paiement (Vice President, Research and Development) will serve as Vice-Chair of the Scientific Advisory Board.
IGX.VN: 0.710 (+0.020)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 167

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 42

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 125

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 305

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 97

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 77

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading

Top 5 Most Recently Viewed Articles

BJ's Wholesale Club Exceeds Expectations with Q4 Earnings

Updated Category News Views 131

BJ's Wholesale Club Achieves Impressive Q4 Results BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has delivered a noteworthy performance in its latest financial results, showcasing resilience and growth in a competitive market. The company's fourth-quarter performance has not only exceeded expectations but also highlighted significant strengths in key operational areas....

Continue Reading
Elemeno Health Appoints Tim Coulter as New CEO for Growth

Updated Category News Views 433

Elemeno Health Welcomes Tim Coulter as New CEO Elemeno Health, a leader in microlearning solutions for healthcare staff, has made a significant announcement regarding its leadership. The company is thrilled to introduce Tim Coulter as its new Chief Executive Officer. With an impressive track record spanning over two decades in health technology and enterprise software,...

Continue Reading
Emerging Trends and Insights in the Amber Glass Packaging Market

Updated Category News Views 152

Growth and Innovation in Amber Glass Packaging The global amber glass packaging market has displayed strong resilience and growth potential. Recent studies indicate that this market, valued at USD 8.46 billion, is projected to reach USD 13.15 billion, indicating a robust compound annual growth rate (CAGR). This surge is driven by the multidimensional advantages of amber...

Continue Reading
FiEE, Inc. Celebrates Trading Resumption on Nasdaq as MINM

Updated Category News Views 273

FiEE, Inc. Announces Trading Resumption on Nasdaq The technology-driven company FiEE, Inc. is excited to share that it will resume trading on the Nasdaq under the existing symbol "MINM". This significant milestone follows a successful hearing with the Nasdaq Hearings Panel, which led to the decision to reinstate trading on the Nasdaq Capital Market. Details of the Trading...

Continue Reading
Vera Therapeutics Expands Talent with Inducement Awards

Updated Category News Views 209

Vera Therapeutics Expands Talent with Inducement Awards Vera Therapeutics, Inc. (Nasdaq: VERA) has recently taken a significant step towards enhancing its workforce by granting inducement awards. These awards, which were declared by the Compensation Committee on January 8, have been established to attract and retain six new employees. The inducement awards include a...

Continue Reading